High sensitivity to tolvaptan in paraneoplastic syndrome of inappropriate ADH secretion (SIADH).
Department of Endocrinology, The Christie, Manchester, UK.
S
S
Kenz
Departments of Medicine I.
C S
CS
Haas
Departments of Medicine I.
S C
SC
Werth
Medicine III, University of Lübeck, Lübeck, Germany.
S
S
Bohnet
Department of Endocrinology, The Christie, Manchester, UK; Departments of Medicine I. Electronic address: Georg.brabant@uk-sh.de.
G
G
Brabant
D000368:Aged; D000369:Aged, 80 and over; D001552:Benzazepines / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007177:Inappropriate ADH Syndrome / Q000188:drug therapy* / Q000401:mortality; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000401:mortality; D008297:Male; D008875:Middle Aged; D045283:Natriuretic Agents / Q000627:therapeutic use*; D009384:Paraneoplastic Endocrine Syndromes / Q000188:drug therapy* / Q000401:mortality; D055752:Small Cell Lung Carcinoma / Q000188:drug therapy* / Q000401:mortality; D000077602:Tolvaptan; D016896:Treatment Outcome
D001552:Benzazepines; D045283:Natriuretic Agents; D000077602:Tolvaptan